Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-2253-25
- Dosage Form
- Injection
- Presentation
- Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25)
- Initial Posting
- Feb 20, 2018